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The present study compares neonatal outcome after preterm
delivery of infants in pregnancies complicated by the HELLP
syndrome or severe preeclampsia (PS). The maternal and
neonatal charts of 71 out of a total of 409 pregnancies that
were complicated by hypertensive disorders at Severance
hospital between January 1995 and December 2004 were
reviewed. Twenty-one pregnancies were complicated by
HELLP syndrome and 50 pregnancies were complicated by
PS. Fifty normotensive (NT) patients who delivered because
of preterm labor comprised the control group. Results were
analyzed by the chi-square test and ANOVA. Gestational age
and maternal age at delivery were matched among the three
groups. The neonatal outcomes of the HELLP syndrome group
were compared with the PS and NT groups. There were sig-
nificant differences between the HELLP syndrome group and
the PS group in the incidence of intraventricular hemorrhage
(IVH) (61.9% vs. 26%, p = 0.006), sepsis (85.7% vs. 44%, p
= 0.003) and mechanical ventilation (MV) rate (81% vs. 54%,
p = 0.039). There were significant differences between the
HELLP syndrome group and the NT group in the incidence
of neonatal death (ND) (19.5% vs. 2.0%, p = 0.034), respira-
tory distress syndrome (RDS) (38.1% vs. 8%, p= 0.0045), IVH
(61.9% vs. 4%, p < 0.0001), sepsis (85.7% vs. 14%, p <
0.0001), intensive care (IC) (85.7% vs. 24%, p < 0.0001) and
MV rate (80.1% vs. 14%, p < 0.0001). There were also signi-
ficant differences between the PS and NT groups in the
incidence of ND (20% vs. 2%, p= 0.0192), RDS (30% vs. 8%,
p = 0.0085), IVH (26% vs. 4%, p = 0.0070), sepsis (44% vs.
14%, p = 0.0015), IC (78% vs. 24%, p < 0.0001), MV rate
(54% vs. 14%, p < 0.0001) and low 5-min APGAR score
(50% vs. 16%, p = 0.0005). This study shows increased mor-
bidity in newborns of mothers complicated with HELLP syn-
drome and indicates that early, regular and high quality man-
agement of these patients is essential to improve both maternal
and neonatal outcome.
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INTRODUCTION
The HELLP syndrome (hemolysis, elevated
liver enzymes, and low platelets) is a variant of
severe preeclampsia that is associated with sig-
nificant maternal and perinatal morbidity and
mortality.
1 Maternal mortality is between 0% and
24%, and perinatal mortality is between 6.6% and
60%.
2,3 Perinatal mortality appears to be primarily
related to the gestational age at delivery. HELLP
syndrome is reported to occur in 20% of women
with severe preeclampsia and in 10% of women
with eclampsia.
3 Studies involving prenatal
management show increased perinatal mortality
rates in cases of HELLP, mainly due to still-
births.
4 However, it does not appear that HELLP
syndrome increases neonatal mortality, irrespec-
tive of gestational age, and data regarding neona-
tal outcomes such as respiratory distress syn-
drome (RDS), intraventricular hemorrhage, necro-
tizing enterocolitis, and sepsis are conflicting.
5-7
The present study compares neonatal outcome
after preterm delivery in pregnancies complicated
by the HELLP syndrome with those complicated
by severe preeclampsia.
MATERIALS AND METHODS
The maternal and neonatal charts of 71 preg-
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nancies complicated by hypertensive disorders at
the perinatal unit in the Severance hospital
between January 1995 and December 2004 were
reviewed.
Twenty-one pregnancies were complicated by
HELLP syndrome and fifty pregnancies were
complicated by severe preeclampsia, Fifty nor-
motensive patients who delivered because of
preterm labor comprised the control group. A
total of 409 pregnancies complicated by hyper-
tensive disorder were enrolled, including 289
pregnancies complicated by severe preeclampsia
(PS).
Patients were diagnosed as preeclamptic if they
met all of the following criteria: systolic blood
pressure > 140 mm Hg or diastolic blood pressure
> 90 mm Hg on two occasions 6 hours apart, pro-
teinuria 2+ or greater on two random samples,
and serum uric acid concentration 5.0 mg/dl.
Gestational age was determined by obstetric
criteria, including menstrual history, early clinical
evaluation, and ultrasonography at < 20 weeks of
gestation where available.
Exclusion criteria included multiple pregnancy,
fetal anomalies, premature rupture of membranes,
and known maternal medical disease. Gestational
age and maternal age at delivery were matched
among the severe preeclampsia, HELLP syndrome
and normotensive groups.
Neonatal medical records were reviewed for
several outcome variables. Respiratory distress
syndrome (RDS) was defined by the presence of
characteristic radiographic findings and an oxy-
gen requirement at 24 h after birth. Intraventri-
cular hemorrhage (IVH) grade 3 was defined as
hemorrhage with ventricular dilation, and IVH
grade 4 as hemorrhage with parenchymal spread.
Necrotizing enterocolitis (NEC) was defined by
characteristic clinical symptoms with radiographic
findings of pneumatosis cystoides intestinalis
(grade 2) or pneumoperitoneum or portal air
(grade 3). Fetal growth restriction (FGR) was de-
fined as a birth weight below the 10th percentile
for the gestational age. Corticosteroid therapy re-
fers to the use of either betamethasone or dexa-
methasone for fetal lung maturation and ranged
from a single dose (at least 12 h before delivery)
to a 48-hour course before delivery. Statistical an-
alyses were performed with the chi-square test
and ANOVA and statistical significance was
considered at p < 0.05.
RESULTS
During the study period, there were 409 pre-
gnancies complicated by hypertensive disorder at
perinatal unit in Severance hospital, 289 of which
were complicated by severe preeclampsia, with or
without HELLP syndrome. 21 cases of HELLP
syndrome were compared with 50 cases of PS and
50 normotensive cases. Tables 1 and 2 compare
maternal demographic and clinical characteristics
for the 3 groups. The incidence of fetal growth re-
striction (FGR) was 4% in the normotensive (NT)
group, 46% in PS (severe preeclampsia) group,
Table 1. Maternal Demographic and Clinical Characteristics
HELLP
(n = 21)
Preeclampsia
(n = 50)
Normotensive preterm
(n = 50)
Significance
(p value)
Age (yr) 32 ± 3.3 31 ± 4.0 30.2 ± 4.5 NS
Nulliparity (%) 57.1 68 42 NS
Male (%) 33.3 44 58 NS
Birth Weight (gm) 1586 ± 478 1390 ± 592 2061 ± 553 NS
Gestational age at delivery (days) 232 ± 19.6 222 ± 23.8 230 ± 16.0 NS
Diagnosis-to-delivery (hours)* 8.5 38 57.4 NS
Values are presented as mean ± SD.
Statistics were analyzed by ANOVA.
NS, not significant.
*median.Neonatal Outcome after Preterm Delivery for HELLP Syndrome
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and 47.6% in HELLP syndrome group (p < 0.05);
these differences were statistically significant.
There were significant differences between NT, PS
and HELLP syndrome in abruptio placentae (2%
vs. 16% vs. 33.3%, p < 0.05), fetal distress (4%
vs.42% vs. 71.4%, p < 0.05), and cesarean delivery
rate (22% vs. 88% vs. 100%, p < 0.0001) (Table 2).
The neonatal outcomes of the HELLP syndrome
group were compared with those of the other
groups (Tables 3, 4). There were significant dif-
ferences between the HELLP syndrome group and
the normotensive group in neonatal death (ND)
(19.5% vs. 2.0%, p = 0.034), respiratory distress
syndrome (RDS) (38.1% vs. 8%, p = 0.0045), intra-
ventricular hemorrhage (IVH) (61.9 vs. 4%, p <
0.0001), sepsis (85.7% vs. 14%, p < 0.0001), inten-
sive care (IC) (85.7% vs. 24%, p < 0.0001), and
mechanical ventilation (MV) rate (81.0% vs. 14%,
p < 0.0001). There were significant differences be-
tween the HELLP syndrome group and the severe
preeclampsia group in intraventricular hemor-
rhage (IVH) (61.9% vs. 26%, p = 0.006), sepsis
Table 2. Comparison of Clinical Characteristics
HELLP*
(n = 21)
Preeclampsia*
(n = 50)
Normotensive
preterm*
(n = 50)
p value
Glucocorticoid therapy 14.3 34 18 NS
Cesarean delivery 100 88 22 < 0.0001
FGR 47.6 46 4 < 0.05
,
IUFD 4.8 10 0 NS
Abruptio placentae 33.3 16 2 < 0.05
,
Fetal distress 71.4 42 4 < 0.05
, ,§
*percent.
Preeclampsia versus Preterm.
HELLP versus Preterm.
§HELLP versus preeclampsia.
NS, not significant; FGR, fetal growth restriction; IUFD, intrauterine fetal death.
Table 3. Comparison of Neonatal Outcome in Pregnancies with HELLP Syndrome and the Normotensive Preterm
Group
HELLP*
(n = 21)
Normotensive preterm*
(n = 50)
OR
(95% CI)
p value
Neonatal death 19.5 2 11.5 (1.2 - 110.4) 0.034
RDS 38.1 8 7.1 (1.8 - 27.3) 0.0045
IVH 61.9 4 39.0 (7.4 - 206.4) < 0.0001
NEC 14.3 0 > 999.9 NS
Sepsis 85.7 14 36.9 (8.6 - 158.7) < 0.0001
Mechanical ventilation 81.0 14 26.1 (6.8 - 100.8) < 0.0001
Intensive care 85.7 24 19.0 (4.8 - 75.8) < 0.0001
5-min APGAR score < 6 66.7 16 0.4 (0.1 - 1.2) NS
*percent.
p < 0.05, by chi-square test.
NS, not significant; RDS, respiratory distress syndrome; IVH, intraventricular hemorrhage; NEC, necrotizing enterocolitisHye Yeon Kim, et al.
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(85.7% vs. 44%, p = 0.003) and mechanical ventila-
tion (MV) rate (81% vs. 54%, p = 0.039).
DISCUSSION
The laboratory abnormalities associated with
HELLP syndrome were described many years ago
and in 1982 Weinstein devised the acronym
HELLP (H = hemolysis, EL = elevated liver en-
zymes, and L = low platelets) to define this spe-
cific subset of severe preeclampsia patients.
2
Maternal mortality is between 0% and 24%, and
perinatal mortality is between 6.6% and 60%.
2,3,7,8
Most published evidence indicates a poor out-
come in cases of HELLP syndrome.
7,9,10 There is
general agreement that both perinatal and infant
morbidity and mortality rates are increased in
pregnancies complicated by HELLP syndrome.
11-12
The ultimate goal of any protocol for the manage-
ment of HELLP syndrome is first to reduce
maternal mortality and morbidity rates, and
second to deliver a healthy and mature baby.
It is important to recognize HELLP syndrome
as a unique form of severe preeclampsia since in
some cases patients have received a non-obstetric
diagnosis, such as cholecystitis or hepatitis, and
proper treatment was delayed. Aggressive treat-
ment with maternal stabilization and expeditious
delivery have been advocated to prevent maternal
and perinatal mortality.
13
Widespread recognition and early diagnosis of
HELLP syndrome as a variant of severe preec-
lampsia have lead to an improvement in maternal
and perinatal outcome. Unfortunately, the only
cure for HELLP syndrome is delivery, even at
early gestational ages.
Abramovici et al. indicated that neonatal mor-
bidity or death is directly related to gestational
age at delivery and showed that prenatal manage-
ment in HELLP syndrome improved neonatal
outcome in cases with advanced gestational age.
15
The present study compared neonatal outcome
of the HELLP syndrome (defined as elevated liver
enzymes and low platelet level, combined with
pregnancy hypertension), versus preeclampsia
without HELLP and a normotensive preterm
group. Neonatal morbidity and mortality was
higher in infants of women with HELLP syn-
drome group than in the normotensive group and
there was a greater need for mechanical ventila-
tion and neonatal intensive care in the HELLP
syndrome group. Neonatal morbidity was also
higher in infants of women with HELLP syn-
drome group than in the severe preeclampsia,
group, and there was a greater need for mechani-
cal ventilation and neonatal intensive care. In
addition, the rates of cesarean delivery, FGR, fetal
distress, IVH, sepsis, lower 5-min APGAR scores
and abruptio placentae were increased in the
Table 4. Comparison of Neonatal Outcome in Pregnancies with HELLP Syndrome and Severe Preeclampsia
HELLP*
(n = 21)
Preeclampsia*
(n = 50)
OR
(95% CI)
p value
Neonatal death 19.5 20 0.9 (0.3 - 3.4) NS
RDS 38.1 30 1.4 (0.5 - 4.1) NS
IVH 61.9 26 4.4 (1.6 - 13.7) 0.006
NEC 14.3 6 2.6 (0.5 - 14.1) NS
Sepsis 85.7 44 7.6 (1.9 - 29.3) 0.003
Mechanical ventilation 81.0 54 3.6 (1.1 - 12.3) 0.039
Intensive care 85.7 78 1.7 (0.4 - 6.8) NS
5-min APGAR score < 6 66.7 50 2.0 (0.7 - 5.8) NS
*percent.
p < 0.05, by chi-square test.
NS, not significant; RDS, respiratory distress syndrome; IVH, intraventricular hemorrhage; NEC, necrotizing enterocolitisNeonatal Outcome after Preterm Delivery for HELLP Syndrome
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HELLP syndrome group.
Halil et al. reported that the adverse impact of
FGR in infants born to mothers with HELLP
syndrome is most prominent beyond 32 weeks.
14
This has recently been supported by evidence that
prematurity associated with adverse neonatal
outcomes such as RDS, IVH, and NEC is largely
unaffected by FGR until the third trimester.
15
After this point, all adverse outcomes were in-
creased in cases of FGR compared with normally
grown premature infants. The present study
showed that FGR was strongly associated with
HELLP syndrome. Therefore, mothers with HELLP
syndrome require close and regular monitoring,
especially beyond 32 weeks.
The higher incidence of fetal distress as well as
the increased blood pressure seen in preeclampsia,
severe form and HELLP syndrome.
Abramovici et al. reported that the median time
from admission to delivery was 0 days for women
with HELLP syndrome and 2 days for women
with severe preeclampsia.
15 There are no data
concerning the neonatal outcome of HELLP syn-
drome with a diagnosis-to-delivery time of more
than 1 day. Future studies are required to address
the neonatal outcome of HELLP syndrome with
prenatal management after admission.
The present study showed no statistical differ-
ences between the severe preeclampsia group and
the HELLP syndrome group in factors affecting
neonatal outcome such as age of the mother,
gestational age, birth weight, fetal growth restric-
tion, cesarean delivery, abruption placentae, and
fetal distress. However, the neonatal outcome of
the HELLP syndrome group showed significantly
increased morbidities in IVH, sepsis, and me-
chanical ventilation treatment rate. This result
indicates that the morbidity of the neonates in the
HELLP syndrome group is higher than that of the
severe preeclampsia group.
This study shows that neonatal morbidity is
increased in pregnancy complicated by the HELLP
syndrome. Thus, management and delivery of
HELLP syndrome mothers and infants should be
performed at tertiary centers, where highly
trained neonatal intensive care unit personnel and
facilities are available, and a team approach with
obstetricians and specialized pediatricians is es-
sential to improve both the maternal and neonatal
outcomes.
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